Indivior PLC Statement re: State Announcements
RNS Number : 7946W
28 April 2021
Statement re: State Announcements
In response to various States Attorney General's recent
announcements regarding SUBOXONE (R) (buprenorphine and naloxone )
Film settlements, Indivior made the following statement:
-- The various state settlement agreements being announced this
week are administrative in nature, and simply formalize the
individual state settlements which were previously agreed to in
principle as part of the July 2020 criminal and civil resolution
between Indivior and the states (and the federal government). As
such, there is no new financial or legal obligation that has
arisen. The Company was pleased to put those issues behind it in
2020 and remains focused on realizing its patient-focused Vision
and fulfilling its compliance commitments.
The Company will have no further comment on this matter.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact email@example.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
(END) Dow Jones Newswires
April 28, 2021 02:00 ET (06:00 GMT)